Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
4.790
+0.020 (0.42%)
At close: May 8, 2026, 4:00 PM EDT
4.600
-0.190 (-3.97%)
After-hours: May 8, 2026, 7:43 PM EDT
Lifecore Biomedical Market Cap
Lifecore Biomedical has a market cap or net worth of $179.67 million as of May 8, 2026. Its market cap has decreased by -21.34% in one year.
Market Cap
179.67M
Enterprise Value
305.93M
1-Year Change
-21.34%
Ranking
Category
Stock Price
$4.79
Market Cap Chart
Since December 1, 1998, Lifecore Biomedical's market cap has increased from $51.30M to $179.67M, an increase of 250.23%. That is a compound annual growth rate of 4.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 179.70M | -41.37% |
| Dec 31, 2025 | 306.50M | 33.49% |
| Dec 31, 2024 | 229.60M | 22.32% |
| Dec 29, 2023 | 187.70M | -2.14% |
| Dec 30, 2022 | 191.80M | -41.35% |
| Dec 31, 2021 | 327.00M | 3.06% |
| Dec 31, 2020 | 317.30M | -3.76% |
| Dec 31, 2019 | 329.70M | 0.33% |
| Dec 31, 2018 | 328.60M | -5.19% |
| Dec 29, 2017 | 346.60M | -7.79% |
| Dec 30, 2016 | 375.90M | 17.62% |
| Dec 31, 2015 | 319.60M | -13.85% |
| Dec 31, 2014 | 371.00M | 15.58% |
| Dec 31, 2013 | 321.00M | 31.29% |
| Dec 31, 2012 | 244.50M | 70.98% |
| Dec 30, 2011 | 143.00M | -9.55% |
| Dec 31, 2010 | 158.10M | -3.89% |
| Dec 31, 2009 | 164.50M | -4.47% |
| Dec 31, 2008 | 172.20M | -50.66% |
| Dec 31, 2007 | 349.00M | 29.79% |
| Dec 29, 2006 | 268.90M | 42.50% |
| Dec 30, 2005 | 188.70M | 18.75% |
| Dec 31, 2004 | 158.90M | 13.58% |
| Dec 31, 2003 | 139.90M | 261.50% |
| Dec 31, 2002 | 38.70M | -36.87% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SIGA Technologies | 344.28M |
| Akebia Therapeutics | 311.18M |
| Organogenesis Holdings | 304.88M |
| Alpha Teknova | 205.33M |
| Aurora Cannabis | 200.41M |
| Anika Therapeutics | 196.52M |
| Organigram Global | 193.14M |
| Cardiol Therapeutics | 147.10M |